Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.1.6.4 (chondroitinase)
 2,039 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Newly synthesized proteoglycans (PG) in proliferating HL-60 cells were labeled with [35S]-sulfate and fractionated on DEAE-cellulose columns. Peak fractions were digested with chondroitinase ABC and separated by paper chromatography. Chondroitin sulfate was identified as the major PG. Treatment of cells with 16 nM TPA resulted in a 1.8-fold increase in total sulfate incorporation into PG, a shift in its location from the cellular to the extracellular compartment, and an increase in the total charge of PG (based on the profile of elution from DEAE-cellulose columns), compared to controls. Incorporation of [3H]-glucosamine into cellular PG was markedly decreased in TPA-treated cells; the sulfate/glucosamine ratio showed a 13.5-fold decrease in the newly synthesized cellular PG. The sulfate/glucosamine ratio, however, was increased by 7.6-fold in secreted PG.
 ...
PMID:Synthesis of proteoglycan during HL-60 cell differentiation. 794 17

The aim of using enzymes in vitreoretinal surgery is to facility PVD and create pharmacological vitrectomy. It can be achieved by liquefying the gel structure of the vitreous (synchisis) and weakening of adherence of the posterior vitreous cortex to retina (syneresis). The article reviews currently used enzymes in vitreoretinal surgery (plasmin, hyaluronidase, dispase, chondroitinase, collagenase, urokinase, TPA--tissue plasminogen activator) and presents potential profits and side-effects related to their use. Although the day when vitreous surgery is replaced by pharmacological vitreolisis remains still as a future, these enzymes hold great promise. Additionally it has been proved that enzymes can be used successfully as an intraoperative adjuvant in vitrectomy.
 ...
PMID:[Use of enzyme in vitreoretinal surgery]. 1204 13